|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
PHAGOCYTES
From the Division of Pulmonary Biology, Children's
Hospital Medical Center, Cincinnati, OH.
Macrophage colony-stimulating factor (M-CSF) is one of several
hematologic growth factors capable of regulating the survival, proliferation, and differentiation of macrophages, but its role in
modulation of the accumulation and function of alveolar macrophages (AMs) in vivo is not well defined. Osteopetrotic (Op/Op) mice have no
detectable M-CSF and show variable tissue-specific reductions in
macrophage numbers. It was hypothesized that AMs would be
decreased in number and have altered function in Op/Op mice because of
the absence of M-CSF. Lung macrophages identified by Mac-3 staining in
lung sections were decreased in number in 20-day-old Op/Op mice
(P < .001) but not Op/Op mice older than 4 months
(P = .68) compared with findings in age-matched
littermate controls. The numbers of AMs recovered by bronchoalveolar
lavage (BAL) were also reduced in young but not adult Op/Op mice
compared with controls. Expression of interleukin-3 (IL-3) was
increased in the lungs of Op/Op mice compared with controls as
determined by quantification of IL-3 cytokine levels
(P = .04), bioactivity (P = .02), and messenger RNA transcript levels. AMs of Op/Op mice spontaneously released higher levels of matrix metalloproteinases (MMPs) than AMs of
controls as determined by immunohistochemical staining of AMs and
zymographic assessment of BAL fluid and AM lysates. Consistent with an increased release of MMP, Op/Op mice had abnormal elastin deposition and spontaneously developed emphysema in the absence
of molecular or cellular evidence of lung inflammation. These data show
that the AM deficiency observed in young Op/Op mice is
spontaneously corrected with age and is associated with increased lung
levels of IL-3, spontaneous MMP expression by AMs, and destruction of
lung tissue.
(Blood. 2001;98:2845-2852) Alveolar macrophages (AMs) are
pulmonary residents of the bone marrow-derived mononuclear phagocyte
system that play a critical role in several diverse lung functions and
in lung host defense.1 AMs arise from circulating blood
monocytes that enter the lungs and other tissues2,3 and
undergo terminal differentiation into tissue macrophage populations
that are heterogeneous in their level of accumulation,4,5
functional activity,4 and expression of cell-surface
molecules.6,7 The mechanisms regulating the abundance and
heterogeneity of AMs and other tissue macrophage populations are not
well defined. However, exposure of macrophages to different tissue
microenvironments varying in the local amount or form of hematologic
growth factors capable of regulating macrophage proliferation has been
proposed.5
Macrophage colony-stimulating factor (M-CSF, also known as CSF-1) is
one of several factors known to regulate the survival, proliferation,
and differentiation of mononuclear phagocytic lineage cells.8 M-CSF is abundant in blood, present in most
tissues (though in lower and various levels depending on the type of
tissue), and expressed as 3 biologically active forms: a circulating
secreted glycoprotein isoform, a proteoglycan isoform, and a
cell-surface isoform produced locally in
tissues.8,9 Recombinant M-CSF was shown to promote
accumulation of murine AMs in vivo10 and survival of human
AMs in vitro,11 and M-CSF levels are increased in the
lungs of smokers in association with significant increases in numbers
of AMs.12 Granulocyte-macrophage
colony-stimulating factor (GM-CSF) and interleukin 3 (IL-3) are also
capable of regulating macrophage proliferation.5,13
AM numbers are increased markedly in transgenic mice
expressing GM-CSF in the lung from a lung-specific transgene.14 However, AM numbers are not
reduced in GM-CSF knockout mice lacking GM-CSF,15,16
suggesting that GM-CSF is not essential for constitutive
accumulation of AMs.
Osteopetrotic mice are homozygous for a naturally occurring recessive
frameshift mutation (Csf-1op or Op) in the M-CSF
gene17 and consequently have no M-CSF.18 They
thus provide a good model for studying the role of M-CSF in vivo. In
Op/Op mice, various M-CSF-dependent macrophage populations are
decreased in number and show developmental anomalies in a tissue-specific manner.5,19,20 For example, bone marrow
monocytes/macrophages, which usually increase progressively with age in
normal mice, are reduced in number in young Op/Op mice.5
However, bone marrow macrophages still increase in number with age in
these mice in parallel with spontaneous correction of
osteopetrosis.21 Macrophage populations that increase
transiently in number at 2 weeks of age in normal mice are reduced in
number, with or without preservation of the transient increase (eg, in
the intestine or periosteum, respectively), or are absent (eg, in
kidneys) in Op/Op mice.5 AMs and pleural macrophages in
Op/Op mice are reduced to 30% and 16%, respectively, of levels in
littermate controls at 2 weeks of age20; however, changes
in AM accumulation with age have not been studied. Administration of
exogenous GM-CSF, IL-3, or both corrects deficiencies in macrophage
accumulation in some but not all tissues in Op/Op mice, thereby
suggesting that one of these factors might have a compensatory
role.22,23 Mice genetically deficient in both M-CSF and
GM-CSF (Op/Op mice with targeted ablation of the GM-CSF locus) still
undergo spontaneous correction of osteopetrosis and hematopoietic
deficiencies, thus demonstrating that GM-CSF is not the compensatory
factor mediating age-dependent changes in macrophage accumulation in
the blood-bone marrow compartment.24
M-CSF and GM-CSF regulate a large number of genes in myeloid
cells,25 including matrix metalloproteinases (MMPs), a
family of proteins whose various functions include tissue
remodeling26,27 and antibacterial host
defense.28 MMP gene expression in macrophages may be
controlled by the relative levels of M-CSF and GM-CSF to which the
cells are exposed because in vitro studies found that GM-CSF stimulates
expression of MMP-12 whereas M-CSF represses MMP-12 expression in
murine macrophages.29 Importantly, increased secretion of
MMP-12 by lung macrophages was also shown to be a critical component of
the mechanism of cigarette-smoke-induced emphysema in
mice.30
The current study was undertaken to define the role of M-CSF in the
regulation of accumulation and function of AMs in the lung in vivo.
Young and adult Op/Op mice were studied to assess age-related effects
on AMs. Because the lung is particularly sensitive to proteases, the
consequences of M-CSF deficiency on MMP expression in AMs were also
evaluated, as were the effects on lung structure.
Mice
Quantification of lung macrophages
Quantification of specific proteins in lungs by enzyme-linked immunosorbent assay Expression of hematologic growth factors in the lungs was assessed in lung homogenates of Op/Op and age-matched littermate controls as described previously, with minor modifications.36 Briefly, lungs were homogenized in 5 mL PBS containing 1% Triton X-100 (Sigma, St Louis, MO) and 1 tablet Complete Mini EDTA Free protease inhibitor mixture (Roche Molecular Biochemicals, Indianapolis, IN). Lysates were cleared of debris by low-speed centrifugation and concentrated 10-fold by ultrafiltration (Centricon 10; Amicon, Bedford, MA). GM-CSF, IL-3, tumor necrosis factor (TNF-), and interleukin 6 (IL-6) were quantified by using
Quantikine enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems,
Minneapolis, MN) in aliquots of lung homogenate containing 80 µg
total protein. M-CSF and G-CSF were also evaluated by ELISAs
established in our laboratory under conditions described in the GM-CSF
Quantikine kit. Capture antibodies were anti-murine M-CSF (Oncogene
Research Products, San Diego, CA) and anti-murine G-CSF (R&D Systems)
antibodies; the detection antibody was a biotinylated, polyclonal
antimurine antibody (R&D Systems). Color development used
avidin-peroxidase complex (Sigma) with
2,2'-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid and hydrogen
peroxide, and quantification was done at 405 nm. Under the assay
conditions used, M-CSF, GM-CSF, G-CSF, IL-3, TNF-, and IL-6 were
detected reproducibly at levels of 6, 1, 4, 1 to 2, 5, and 3 pg/mL,
respectively, in lung homogenates. Surfactant protein D (SP-D) levels
were measured in lung homogenates by using ELISAs as described
previously.37
Quantification of IL-3 messenger RNA transcript levels Total-lung RNA was purified from the lungs of Op/Op mice and littermate controls and subjected to reverse transcriptase (RT)-PCR amplification using oligonucleotide primers specific for the IL-3 gene as described previously.35Quantification of IL-3 bioactivity Op/Op mice and age-matched controls were killed at ages ranging from 3 to 6 months, and the lungs were lavaged with 5 1-mL aliquots of PBS. IL-3 bioactivity was then assessed in lysates using IL-3-growth responsive M-NFS-60 cells (R&D Systems) as described in the product literature for the anti-mouse IL-3 neutralizing antibody (R&D systems). Briefly, cells were plated as described and incubated for 24 hours in medium containing BAL (50 µL) preincubated with 1 µg anti-murine M-CSF antibody (Oncogene Research Products) to neutralize any M-CSF (present in control lysates). Cell growth was assessed by tritium-thymidine incorporation into DNA.AM morphologic studies AMs were recovered from Op/Op mice and control mice, washed, and evaluated by cytocentrifugation and Diff-Quick staining as described above. AM cell size was determined from digital photomicrographs by measuring the area of each cell with use of the "total area" and "equivalent radius" functions of the Metamorph software. More than 100 cells were evaluated for each determination.Expression of MMPs AMs were obtained by BAL and evaluated for MMP expression by immunohistochemical staining as described previously33 by using goat anti-mouse primary antibodies to MMP-2, MMP-9, or MMP-12 (Santa Cruz Biotechnology, Santa Cruz, CA; diluted 1:500, 1:500, and 1:400, respectively).MMP enzyme activity levels in BAL fluid and BAL cell lysates were evaluated by zymography as described previously.38 Briefly, BAL was collected from 2-month-old Op/Op or control mice, cells were recovered by centrifugation (500g for 7 minutes), and BAL fluid was concentrated 10-fold by using Centricon 10 filters. BAL fluid (10 µL) or cells (1.5 × 105 cells/mouse) were mixed with 10 µL Laemmli sample buffer (Bio-Rad, Hercules, CA) and electrophoresed on 1-mm-thick zymogram gels (Novex, San Diego, CA; 10% gelatin for BAL and 12% casein for cells) under nonreducing conditions. Gels were then washed in 2.5% Triton X-100 for 1 hour with gentle agitation on an orbital shaker; incubated (24 hours for BAL and 72 hours for cells) in 40 mM Tris-hydrochloric acid (pH 7.5), 10 mM calcium chloride, and 1 µM zinc chloride to permit digestion of gelatin and casein at the positions of the electrophoretic bands of proteolytic activity in the gel; stained for 3 hours using a colloidal blue staining kit (Novex); and destained with distilled water. Molecular weights were determined from prestained standards (Novex). To determine whether IL-3 stimulates MMP release from AMs in the lung in vivo, recombinant IL-3 (R&D Systems) or PBS (control) was administered (100 ng/mouse) endotracheally into the lungs of wild-type mice. Forty-eight hours later, BAL was recovered and evaluated for the presence of MMP by zymography as described above. To determine whether the effect of IL-3 on macrophage MMP expression was direct or indirect, murine RAW264.7 macrophages were cultured in Dulbecco modified Eagle medium in the absence or presence of IL-3 (100 ng/mL) with or without cycloheximide (10 µg/mL) for 3 hours. Total RNA was then extracted and evaluated for MMP-2, MMP-9, and MMP-2 messenger mRNA (mRNA) transcripts using RT-PCR amplification as described above and the following oligonucleotide primers: 5'-CCACGCTGTGGTGTCCCAGACGTG-3' and 5'-GAACTCGTGCGCTGCCACCAGGAA-3' for MMP-2; 5'-TTGAGTCCGGCAGAC AATCCTTGC-3' and 5'-CCTTATCCACGCGAATGACGCTCT-3' for MMP-9; and 5'-TCGATGTGGAGTGCCCGATGTACA-3' and 5'-ACGTATGTCATCAGCAGAGAGGCG-3' for MMP-12. Lung histopathological studies Op/Op and control mice were killed at various ages ranging from 20 to 210 days, and lung histologic features were evaluated by light microscopy as described previously.35 Separate slides were stained with Masson trichrome or orcein stain and examined to assess the content and pattern of collagen or elastin deposition, respectively.33 The degree of pulmonary airway enlargement was quantified by morphometric analysis as described previously.33Statistical analysis Numeric data are presented as means ± standard error of the mean. Statistical comparisons were made using Student t tests. Statistical calculations were done with Sigma Plot software (version 4.0; SPSS, Chicago, IL).
AMs are deficient in young but not adult Op/Op mice The intensity of Mac-3 surface antigen staining of lung macrophages was homogenous and similar in positive cells from both Op/Op and control mice of all ages (Figure 1A-D). Morphometric quantification of Mac-3-positive (Mac-3+) cells showed that lung macrophages were significantly reduced in young Op/Op mice compared with littermate controls (Figure 1E). In contrast, the numbers of Mac-3+ cells were similar in adult Op/Op and control mice (Figure 1F). Although the number of Mac-3+ cells in the lungs of control mice declined significantly with increasing age, no such age-related decrease occurred in Op/Op mice.
Evaluation of cells recovered by BAL from Op/Op mice and age-matched
littermate controls showed that AMs were relatively deficient in young
but not adult Op/Op mice (Figure 2).
Regression analysis of data from Op/Op mice aged 53 to 158 days showed
little change in AM numbers with age (Figure 2A), a finding consistent
with immunohistochemical data (Figure 1). Similar analysis of AMs in control mice found a significant reduction in AM numbers in adult compared with young mice (Figure 2B). Extrapolation of these regression equations (with data shown in Figure 2) to 20 days showed an AM deficiency in young Op/Op mice compared with littermate controls (6.06 versus 13.6 × 104 AMs/mouse, respectively), in agreement
with previously reported data20 and the Mac-3 staining
data (Figure 1).
Lung expression of colony-stimulating factors is altered in Op/Op mice To evaluate possible compensatory expression of an alternative macrophage growth factor in the lungs of Op/Op mice, levels of GM-CSF, G-CSF, IL-3, and as a control, M-CSF were measured in lung homogenates of Op/Op mice and age-matched littermate controls (Figure 3A). As expected, M-CSF was not present in the lungs of Op/Op mice but was easily detected in control mice. GM-CSF was detected in both but at similarly low levels in Op/Op mice and controls. G-CSF was detected in the lungs of both Op/Op and control mice, with slightly higher levels in Op/Op mice. IL-3 levels were markedly higher in the lungs of Op/Op mice than in those of controls. To confirm increased IL-3 expression in the lungs in Op/Op mice, RT-PCR was used to evaluate IL-3 mRNA transcript levels in total-lung RNA. IL-3 mRNA transcripts were easily detected in 5 of 6 Op/Op mice but were detected in only 1 of 6 littermate controls (Figure 3B). To evaluate further the possible compensatory role of IL-3 in Op/Op mice, IL-3 bioactivity was also quantified. IL-3 bioactivity was found to be increased significantly in BAL of Op/Op mice compared with homogenates of littermate controls (Figure 3C).
AM morphologic features Light-microscopic evaluation of BAL cells stained with Diff-Quick revealed no differences in the proportion of macrophages in young or adult Op/Op and control mice (> 95% in all cases; Figure 4A-D). However, AMs of young Op/Op mice were significantly smaller, appeared less mature, and had less cytoplasm (Figure 4A) than those of age-matched littermate controls (Figure 4B). Morphometric analysis confirmed this finding, showing AM cell diameters of 14.2 ± 0.31 µm in young Op/Op mice and 16.0 ± 0.27 µm in control mice (Figure 4E). There were no differences in AM cell diameters in adult Op/Op and adult control mice (Figure 4F), although the mean diameter in both was larger than that in young mice. Standard transmission electron microscopy revealed no ultrastructural differences in AMs of adult Op/Op and control mice (data not shown).
AMs in Op/Op mice spontaneously express MMPs in vivo We hypothesized that MMP expression may be increased in AMs of Op/Op mice because in vitro studies showed that expression of MMP-2, MMP-9, and MMP-12 genes are regulated by the relative levels of GM-CSF and M-CSF29 and because Op/Op mice express GM-CSF normally in the lung but do not express detectable levels of M-CSF (Figure 3). AMs of Op/Op but not control mice showed positive cytoplasmic staining for several MMPs (Figure 5). Some AMs in Op/Op mice stained strongly for MMP-2 (gelatinase A), MMP-9 (gelatinase B), or MMP-12 (macrophage metalloelastase). In contrast, no AMs from control mice stained strongly for any MMP, only a few cells showed any staining at all, and that staining was minimal.
To assess functional MMP activity in the lung, BAL fluid from Op/Op and
control mice was evaluated by using gelatin zymography (Figure
6A). A strong band of proteolytic
activity at 72 kd, corresponding in size to gelatinase A, was observed
in Op/Op mice and was especially prominent in some animals.
Although a band of similar size was detected in BAL fluid of control
mice, the activity was reduced markedly. A band of proteolytic activity
at 92 kd, corresponding in size to gelatinase B, was present in BAL
fluid of all 4 Op/Op mice but no BAL fluid of controls. A third
proteolytic activity at 22 kd, corresponding in size to MMP-12, was
observed in BAL fluid of 3 of 4 Op/Op mice but was not detected in any
BAL sample from controls. Casein zymograms confirmed the presence of
the 22-kd proteolytic activity in AMs of Op/Op mice at levels clearly higher than in AMs of controls (Figure 6B). All these proteolytic activities were inhibited by EDTA, as expected for MMP enzyme activities (data not shown).
To determine the possible role of increased IL-3 levels in stimulation of MMP expression by AMs in vivo in Op/Op mice, IL-3 or PBS (control) was administered into the lungs of wild-type mice and MMP expression was evaluated 48 hours later. Zymography showed easily detected bands at 92 kd and 72 kd in mice exposed to IL-3 but not in those exposed to PBS (Figure 6C). Exposure of murine RAW264.7 macrophages to similar concentrations of IL-3 in vitro stimulated mRNA transcript levels for MMP-12 and, to a lesser extent, MMP-2 and MMP-9 (Figure 6D). Cycloheximide only partly reduced the IL-3-stimulated increase in MMP-12 mRNA transcripts and had minimal effect on MMP-2 and MMP-9 mRNA. Together, these results suggest that the stimulation of MMP expression is a direct effect of IL-3. Op/Op mice spontaneously develop pulmonary emphysema To evaluate the biochemical and functional consequences of spontaneous MMP release in the lungs of Op/Op mice, lung tissues were evaluated by using routine histologic studies, special stains to assess abnormalities in elastin and collagen deposition, and morphometric analysis to quantify derangements of sensitive lung-tissue structures. No histopathological abnormalities were detected in Op/Op mice or controls that were 20 days of age (Figure 7A-B). However, at 120 days of age, Op/Op but not control mice had airspace enlargement typical of panlobular emphysema (Figure 7C-D). Emphysema in Op/Op mice had worsened by 210 days while the lungs of age-matched controls remained normal (Figure 7E-F). Morphometric analysis showed similar values for the fractional area of airspace in young Op/Op and control mice (Figure 7G-H). However, linear regression analysis showed that the fractional area of airspace increased progressively and significantly with age in Op/Op mice, at a rate of 3.6 ± 0.6 × 10 2 %/day
(Figure 7G). In contrast, no such change was observed in age-matched
control mice and the slope of the regression line was not significantly
different from zero (Figure 7H). Orcein histochemical staining showed
that elastin deposition was normal in the lungs of young (20-day-old)
Op/Op and control mice but was disordered in the lungs of adult Op/Op
mice (aged 120 and 210 days; data not shown). Evaluation of deposition
of collagen in the lungs by using Masson trichrome staining revealed no
alterations in the pattern of collagen fibrils in the lungs of Op/Op or
control mice at any age (data not shown). Histologic evaluation of the lungs of Op/Op mice of all ages did not detect an inflammatory cell
infiltrate (Figure 7A-F), thereby suggesting that nonspecific inflammation was not an etiologic factor in the development of emphysema.
To explore further the possibility that occult inflammation was
present, lung homogenates of Op/Op and control mice were evaluated by
ELISA for proinflammatory cytokines TNF-
In this study, we sought information on the in vivo role of M-CSF in constitutive AM accumulation and function in the lungs by using the M-CSF-deficient Op/Op mouse model. Using several approaches, we found that AMs were relatively deficient in young Op/Op mice but normal in adult Op/Op mice. The small size and ultrastructural abnormalities previously described in AMs of young Op/Op mice39 were not present in AMs of adult Op/Op mice. Although GM-CSF levels in Op/Op and control mice were not different, IL-3 expression was greater in the lungs of Op/Op mice than in those of controls as determined by quantification of IL-3 cytokine levels, mRNA transcripts, and bioactivity. MMP-2, MMP-9, and MMP-12 levels were abnormally elevated in AMs and BAL of Op/Op mice and were associated with spontaneous development of pulmonary emphysema. Taken together, these data are consistent with the idea that IL-3 may compensate for the M-CSF deficiency in the lungs of Op/Op mice, resulting in preservation of AM numbers, but that this compensatory role may be associated with stimulation of MMP expression that contributes to structural damage in the lungs. A major focus of this study was to determine the role of endogenous M-CSF expression in regulation of constitutive accumulation of AMs in the lung. The observation of a relative deficiency of AMs in Op/Op mice (~ 65% of levels in littermate controls) aged 20 days is supported by studies showing that AM numbers are reduced to about 30% of control values at 14 days of age20 and that lung F4/80-positive cells in Op/Op mice are reduced to 8% of control values at 7 days of age.40 The observation that AM numbers are normal in adult Op/Op mice is novel but is consistent with previous findings of a spontaneous, age-dependent correction in hematologic abnormalities, numbers of macrophages and osteoclasts in bone marrow, and osteopetrosis of Op/Op mice.21 Thus, our results and previously reported data show that AM accumulation in Op/Op mice is most severely affected in young mice and that this abnormality is not present in adult mice. These data can be interpreted in 2 different ways. First, M-CSF may have a relatively greater importance in the perinatal and neonatal period than in adulthood. Interestingly, the period of relative deficiency coincides with postnatal alveolarization of the lung in mice.41 This suggests a possible role for M-CSF in stimulation of lung macrophage functions during alveolarization, for example, clearance of cells and macromolecular debris left over from tissue remodeling. Alternatively, M-CSF may be important for normal AM function throughout life. In either case, factors in addition to M-CSF are responsible for constitutive accumulation of AMs in the lungs, suggesting a functional overlap of M-CSF with one or more other factors that can compensate for the absence of M-CSF in Op/ Op mice. Several lines of evidence support the idea that increased expression of IL-3 in the lungs may compensate for the M-CSF deficiency and stimulate AM accumulation in Op/Op mice. First, levels of IL-3 protein, mRNA, and bioactivity were significantly higher in the lungs of Op/Op mice than in those of littermate controls. Second, IL-3 is capable of stimulating macrophage accumulation in vivo.22 Third, administration of exogenous IL-3 to Op/Op mice corrects some of the macrophage abnormalities in those mice.22 Although local expression of GM-CSF can increase AM accumulation in the lung,14 GM-CSF levels were not higher in the lungs of Op/Op mice than in those of controls. Furthermore, GM-CSF expression is not responsible for correction of the hematologic abnormalities in Op/Op mice because M-CSF-deficient Op/Op mice that are also deficient in GM-CSF as a result of targeted gene ablation still undergo age-dependent correction of hematologic abnormalities.24 Although G-CSF was slightly elevated in Op/Op mice, neutrophil accumulation was not observed, suggesting that the differences were not functionally important. Significant, spontaneous expression of MMPs by AMs in Op/Op mice was an important finding of this study and was supported by results obtained by using several independent experimental approaches. These results were (1) increased MMP levels in AMs on immunohistochemical staining, (2) increased MMP activities in BAL fluid on zymography, (3) derangement of elastin fiber deposition in lung tissue, (4) development of emphysema confirmed by histopathological evaluation and morphometric analysis showing progressive loss of lung parenchyma and increase in the fractional area of airspace with age, and (5) IL-3-stimulated increases in MMP levels in the lungs of normal mice and higher IL-3 levels in Op/Op mice than in controls. Development of emphysema in the Op/Op mice did not appear to be due to nonspecific inflammation because neither cellular nor molecular evidence of parenchymal inflammation was observed. Although starvation is associated with emphysema in rats,42 there was no decrease in elastin or collagen in the Op/Op mice in our study, as would be expected with this cause of emphysema.43 Moreover, although the Op/Op mice were smaller than controls, they gained weight as they grew older. The idea that increased expression of IL-3 in the lungs of Op/Op mice might constitute the molecular explanation for stimulation of MMP release by AMs is supported by the finding that IL-3 stimulates MMP-2 and MMP-9 expression in other hematopoietic cells (eg, CD34+ blood mononuclear cells).44 Alternatively, it is possible that an imbalance of M-CSF and GM-CSF levels to which AMs are exposed in the lungs of Op/Op mice is predominantly responsible for increased MMP expression, since M-CSF is absent and GM-CSF levels are normal in the lungs of such mice (Figure 3). This hypothesis is consistent with data showing that GM-CSF stimulates and M-CSF suppresses MMP gene expression in peritoneal macrophages.29 Finally, it is possible that both these molecular mechanisms are operating in the lungs of Op/Op mice. Regardless of whether one or both are responsible, the development of emphysema shows that MMP release is functionally important, since the lung is very sensitive to protease-antiprotease balance and expression of MMP-12 in macrophages is a requirement for the development of smoking-induced emphysema in mice.30
We thank Susan Wert for help with the morphometric analysis and William Hull for help with the SP-D ELISA analysis.
Submitted January 12, 2001; accepted July 3, 2001.
Supported by the Children's Hospital Research Foundation, Cincinnati, OH.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Bruce C. Trapnell, Children's Hospital Medical Center, Division of Pulmonary Biology, 3333 Burnet Ave, Cincinnati, OH 45229; e-mail: bruce.trapnell{at}chmcc.org.
1. Green GM, Jakab GJ, Low RB, Davis GS. Defense mechanisms of the respiratory membrane. Am Rev Respir Dis. 1977;115:479-514[Medline] [Order article via Infotrieve].
2.
Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW.
Direct evidence for a bone marrow origin of the alveolar macrophage in man.
Science.
1976;192:1016-1018
3.
Kennedy DW, Abkowitz JL.
Mature monocytic cells enter tissues and engraft.
Proc Natl Acad Sci U S A.
1998;95:14944-14949 4. Gordon S, Keshav S, Chung LP. Mononuclear phagocytes: tissue distribution and functional heterogeneity. Curr Opin Immunol. 1988;1:26-35[CrossRef][Medline] [Order article via Infotrieve]. 5. Cecchini MG, Dominguez MG, Mocci S, et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development. 1994;120:1357-1372[Abstract]. 6. de Bruijn MF, Slieker WA, van der Loo JC, Voerman JS, van Ewijk W, Leenen PJ. Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur J Immunol. 1994;24:2279-2284[Medline] [Order article via Infotrieve]. 7. Naito M, Umeda S, Yamamoto T, et al. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. J Leukoc Biol. 1996;59:133-138[Abstract]. 8. Stanley ER, Berg KL, Einstein DB, et al. Biology and action of colony-stimulating factor-1. Mol Reprod Dev. 1997;46:4-10[CrossRef][Medline] [Order article via Infotrieve]. 9. Motoyoshi K. Function, molecular structure and gene expression of macrophage colony-stimulating factor [in Japanese]. Nippon Rinsho. 1992;50:1861-1866[Medline] [Order article via Infotrieve]. 10. Held TK, Mielke ME, Unger M, Trautmann M, Cross AS. Kinetics and dose dependence of macrophage colony-stimulating factor-induced proliferation and activation of murine mononuclear phagocytes in situ: differences between lungs, liver, and spleen. J Interferon Cytokine Res. 1996;16:159-168[Medline] [Order article via Infotrieve].
11.
Marsh CB, Pomerantz RP, Parker JM, et al.
Regulation of monocyte survival in vitro by deposited IgG: role of macrophage colony-stimulating factor.
J Immunol.
1999;162:6217-6225 12. Rose RM, Kobzik L, Filderman AE, Vermeulen MW, Dushay K, Donahue RE. Characterization of colony stimulating factor activity in the human respiratory tract: comparison of healthy smokers and nonsmokers. Am Rev Respir Dis. 1992;145:394-399[Medline] [Order article via Infotrieve]. 13. Akagawa KS, Kamoshita K, Tokunaga T. Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages. J Immunol. 1988;141:3383-3390[Abstract]. 14. Huffman JA, Hull WM, Dranoff G, Mulligan RC, Whitsett JA. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest. 1996;97:649-655[Medline] [Order article via Infotrieve].
15.
Dranoff G, Crawford AD, Sadelain M, et al.
Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.
Science.
1994;264:713-716
16.
Stanley E, Lieschke GJ, Grail D, et al.
Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.
Proc Natl Acad Sci U S A.
1994;91:5592-5596 17. Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 1990;345:442-444[CrossRef][Medline] [Order article via Infotrieve].
18.
Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, et al.
Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.
Proc Natl Acad Sci U S A.
1990;87:4828-4832 19. Naito M, Hayashi S, Yoshida H, Nishikawa S, Shultz LD, Takahashi K. Abnormal differentiation of tissue macrophage populations in `osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor. Am J Pathol. 1991;139:657-667[Abstract]. 20. Wiktor-Jedrzejczak W, Ratajczak MZ, Ptasznik A, Sell KW, Ahmed-Ansari A, Ostertag W. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol. 1992;20:1004-1010[Medline] [Order article via Infotrieve].
21.
Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I.
Delayed hematopoietic development in osteopetrotic (op/op) mice.
J Exp Med.
1993;177:237-242
22.
Myint YY, Miyakawa K, Naito M, et al.
Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation.
Am J Pathol.
1999;154:553-566
23.
Wiktor-Jedrzejczak W, Urbanowska E, Szperl M.
Granulocyte-macrophage colony-stimulating factor corrects macrophage deficiencies, but not osteopetrosis, in the colony-stimulating factor-1-deficient op/op mouse.
Endocrinology.
1994;134:1932-1935
24.
Nilsson SK, Lieschke GJ, Garcia-Wijnen CC, et al.
Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse.
Blood.
1995;86:66-72
25.
Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima K.
Serial analysis of gene expression in human monocytes and macrophages.
Blood.
1999;94:837-844
26.
Gronski TJ Jr, Martin RL, Kobayashi DK, et al.
Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase.
J Biol Chem.
1997;272:12189-12194 27. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 1998;10:602-608[CrossRef][Medline] [Order article via Infotrieve]. 28. Hartzell W, Shapiro SD. Macrophage elastase is required for macrophage intracellular anti-microbial activity. Am J Respir Crit Care Med. 1999;161:A217. 29. Kumar R, Dong Z, Fidler IJ. Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J Immunol. 1996;157:5104-5111[Abstract].
30.
Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD.
Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.
Science.
1997;277:2002-2004
31.
Lieschke GJ, Stanley E, Grail D, et al.
Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease.
Blood.
1994;84:27-35
32.
Zsengeller ZK, Otake K, Hossain S-A, Berclaz P-Y, Trapnell BC.
Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection.
J Virol.
2000;74:9655-9667
33.
Wert SE, Yoshida M, LeVine AM, et al.
Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice.
Proc Natl Acad Sci U S A.
2000;97:5972-5977 34. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991;39:741-748[Abstract]. 35. Otake K, Ennist DL, Harrod K, Trapnell BC. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum Gene Ther. 1998;10:2207-2222.
36.
Harrod KS, Trapnell BC, Otake K, Korfhagen TR, Whitsett JA.
SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection.
Am J Physiol.
1999;277:L580-L588
37.
Fisher JH, Sheftelyevich V, Ho YS, et al.
Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice.
Am J Physiol Lung Cell Mol Physiol.
2000;278:L365-L373
38.
Gibbs DF, Warner RL, Weiss SJ, Johnson KJ, Varani J.
Characterization of matrix metalloproteinases produced by rat alveolar macrophages.
Am J Respir Cell Mol Biol.
1999;20:1136-1144 39. Usuda H, Naito M, Umeda S, Takahashi K, Shultz LD. Ultrastructure of macrophages and dendritic cells in osteopetrosis (op) mutant mice lacking macrophage colony-stimulating factor (M-CSF/CSF-1) activity. J Submicrosc Cytol Pathol. 1994;26:111-119[Medline] [Order article via Infotrieve].
40.
Roth P, Dominguez MG, Stanley ER.
The effects of colony-stimulating factor-1 on the distribution of mononuclear phagocytes in the developing osteopetrotic mouse.
Blood.
1998;91:3773-3783 41. Amy RW, Bowes D, Burri PH, Haines J, Thurlbeck WM. Postnatal growth of the mouse lung. J Anat. 1977;124:131-151[Medline] [Order article via Infotrieve]. 42. Sahebjami H, Wirman JA. Emphysema-like changes in the lungs of starved rats. Am Rev Respir Dis. 1981;124:619-624[Medline] [Order article via Infotrieve]. 43. Sahebjami H, MacGee J. Changes in connective tissue composition of the lung in starvation and refeeding. Am Rev Respir Dis. 1983;128:644-647[Medline] [Order article via Infotrieve].
44.
Janowska-Wieczorek A, Marquez LA, Nabholtz JM, et al.
Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane.
Blood.
1999;93:3379-3390
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  M. Suzuki, I. Tachibana, Y. Takeda, P. He, S. Minami, T. Iwasaki, H. Kida, S. Goya, T. Kijima, M. Yoshida, et al. Tetraspanin CD9 Negatively Regulates Lipopolysaccharide-Induced Macrophage Activation and Lung Inflammation J. Immunol., May 15, 2009; 182(10): 6485 - 6493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Takeda, P. He, I. Tachibana, B. Zhou, K. Miyado, H. Kaneko, M. Suzuki, S. Minami, T. Iwasaki, S. Goya, et al. Double Deficiency of Tetraspanins CD9 and CD81 Alters Cell Motility and Protease Production of Macrophages and Causes Chronic Obstructive Pulmonary Disease-like Phenotype in Mice J. Biol. Chem., September 19, 2008; 283(38): 26089 - 26097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Bonfield, M. J. Thomassen, C. F. Farver, S. Abraham, M. T. Koloze, X. Zhang, D. M. Mosser, and D. A. Culver Peroxisome Proliferator-Activated Receptor-{gamma} Regulates the Expression of Alveolar Macrophage Macrophage Colony-Stimulating Factor J. Immunol., July 1, 2008; 181(1): 235 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Kelly, K. McNagny, D. L. Williams, N. van Rooijen, L. Maxwell, C. Gwozd, C. H. Mody, and P. Kubes The Lung Responds to Zymosan in a Unique Manner Independent of Toll-Like Receptors, Complement, and Dectin-1 Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 227 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Grayson, M. S. Ramos, M. M. Rohlfing, R. Kitchens, H. D. Wang, A. Gould, E. Agapov, and M. J. Holtzman Controls for Lung Dendritic Cell Maturation and Migration during Respiratory Viral Infection J. Immunol., August 1, 2007; 179(3): 1438 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Hibbs, C. Quilici, N. Kountouri, J. F. Seymour, J. E. Armes, A. W. Burgess, and A. R. Dunn Mice Lacking Three Myeloid Colony-Stimulating Factors (G-CSF, GM-CSF, and M-CSF) Still Produce Macrophages and Granulocytes and Mount an Inflammatory Response in a Sterile Model of Peritonitis J. Immunol., May 15, 2007; 178(10): 6435 - 6443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-i. Machiya, Y. Shibata, K. Yamauchi, N. Hirama, T. Wada, S. Inoue, S. Abe, N. Takabatake, M. Sata, and I. Kubota Enhanced Expression of MafB Inhibits Macrophage Apoptosis Induced by Cigarette Smoke Exposure Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 418 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. M. Wang, H. P. Kim, R. Song, and A. M. K. Choi Caveolin-1 Confers Antiinflammatory Effects in Murine Macrophages via the MKK3/p38 MAPK Pathway Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Foronjy, O. Mirochnitchenko, O. Propokenko, V. Lemaitre, Y. Jia, M. Inouye, Y. Okada, and J. M. D'Armiento Superoxide Dismutase Expression Attenuates Cigarette Smoke- or Elastase-generated Emphysema in Mice Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 623 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P T G Elkington and J S Friedland Matrix metalloproteinases in destructive pulmonary pathology Thorax, March 1, 2006; 61(3): 259 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Bonfield, C. M. Swaisgood, B. P. Barna, C. F. Farver, M. S. Kavuru, and M. J. Thomassen Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor J. Leukoc. Biol., January 1, 2006; 79(1): 133 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. D'hulst, K. Y. Vermaelen, G. G. Brusselle, G. F. Joos, and R. A. Pauwels Time course of cigarette smoke-induced pulmonary inflammation in mice Eur. Respir. J., August 1, 2005; 26(2): 204 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Modarai, K.G. Burnand, B. Sawyer, and A. Smith Endothelial Progenitor Cells Are Recruited Into Resolving Venous Thrombi Circulation, May 24, 2005; 111(20): 2645 - 2653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bonniaud, M. Kolb, T. Galt, J. Robertson, C. Robbins, M. Stampfli, C. Lavery, P. J. Margetts, A. B. Roberts, and J. Gauldie Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-{beta}-Mediated Pulmonary Fibrosis J. Immunol., August 1, 2004; 173(3): 2099 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shishido, N. Nozaki, S. Yamaguchi, Y. Shibata, J. Nitobe, T. Miyamoto, H. Takahashi, T. Arimoto, K. Maeda, M. Yamakawa, et al. Toll-Like Receptor-2 Modulates Ventricular Remodeling After Myocardial Infarction Circulation, December 9, 2003; 108(23): 2905 - 2910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-Y. Berclaz, Z. Zsengeller, Y. Shibata, K. Otake, S. Strasbaugh, J. A. Whitsett, and B. C. Trapnell Endocytic Internalization of Adenovirus, Nonspecific Phagocytosis, and Cytoskeletal Organization Are Coordinately Regulated in Alveolar Macrophages by GM-CSF and PU.1 J. Immunol., December 1, 2002; 169(11): 6332 - 6342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-Y. Berclaz, Y. Shibata, J. A. Whitsett, and B. C. Trapnell GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung Blood, December 1, 2002; 100(12): 4193 - 4200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Mahadeva and S D Shapiro Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema Thorax, October 1, 2002; 57(10): 908 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Le Meur, G. H. Tesch, P. A. Hill, W. Mu, R. Foti, D. J. Nikolic-Paterson, and R. C. Atkins Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway J. Leukoc. Biol., September 1, 2002; 72(3): 530 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J C Hogg and R M Senior Chronic obstructive pulmonary disease c 2: Pathology and biochemistry of emphysema Thorax, September 1, 2002; 57(9): 830 - 834. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
515 ± 241 cells/mouse per day; R = 0.45; P = .046).
-actin-specific
oligonucleotide primers. IL-3 mRNA was detected in the lungs of 5 of 6 Op/Op mice but in only 1 of 6 control mice. In contrast, 
